E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Virology

• Publication date

  1996-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.70.12.8558-8563.1996PMID 8970980PMCID PMC190948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of E5a and E7 genes of human papillomavirus type 11 on immortalized human epidermal keratinocytes and NIH 3T3 cells

  2005cited by this paper
• The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein

  2005cited by this paper
• Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes

  1996cited by this paper
• Mutational analysis of human papillomavirus type 11 E5a oncoprotein

  1996influential reference
• Differential induction and regulation of c-jun, junB, junD and c-fos by human papillomavirus type 11 E5a oncoprotein.

  1995influential reference
• The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells.

  1995cited by this paper
• The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression.

  1994cited by this paper
• The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors.

  1994cited by this paper
• E5a gene of human papillomavirus type 11 is required for initiation but not for maintenance of transformation in NIH 3T3 cells.

  1994cited by this paper
• Construction of site-specific mutants of E5A protein of HPV-11 using the polymerase chain reaction and a single mutant primer.

  1993cited by this paper
• The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein

  1993cited by this paper
• Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes

  1993cited by this paper
• The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes

  1993cited by this paper
• Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences.

  1993cited by this paper
• The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus.

  1992cited by this paper
• The -6.1-kilobase chicken lysozyme enhancer is a multifactorial complex containing several cell-type-specific elements

  1992cited by this paper
• Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes.

  1992cited by this paper
• The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription

  1991cited by this paper
• Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16

  1991cited by this paper
• Multiple basal promoter elements determine the level of human c-fos transcription

  1991cited by this paper
• Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines

  1991cited by this paper
• Proteins of the nuclear factor-1 family act as an activator of the late promoter in human polyomavirus BK in vitro.

  1991cited by this paper
• Human papillomaviruses in the pathogenesis of anogenital cancer.

  1991cited by this paper
• Role of the human papillomaviruses in human cancer.

  1991cited by this paper
• Protein-protein interactions between adenovirus DNA polymerase and nuclear factor I mediate formation of the DNA replication preinitiation complex.

  1990cited by this paper
• Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.

  1990cited by this paper
• Amino‐terminal domain of NF1 binds to DNA as a dimer and activates adenovirus DNA replication.

  1990cited by this paper
• Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells

  1990cited by this paper
• Demonstration in living cells of an intragenic negative regulatory element within the rodent c-fos gene.

  1990cited by this paper
• The adenovirus EIIA enhancer. Analysis of regulatory sequences and changes in binding activity of ATF and EIIF following adenovirus infection.

  1989cited by this paper
• An AP1-binding site in the c-fos gene can mediate induction by epidermal growth factor and 12-O-tetradecanoyl phorbol-13-acetate

  1989cited by this paper
• The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain.

  1989cited by this paper
• The c-fos serum response element responds to protein kinase C-dependent and -independent signals but not to cyclic AMP.

  1988cited by this paper
• c-fos Sequences Necessary forBasalExpression andInduction by Epidermal GrowthFactor, 12-0-Tetradecanoyl Phorbol-13-Acetate, andtheCalcium lonophore

  1987cited by this paper
• The fos oncogene.

  1987cited by this paper
• Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene.

  1986cited by this paper
• High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter.

  1986cited by this paper
• The TGGCA protein binds to the MMTV-LTR, the adenovirus origin of replication, and the BK virus enhancer.

  1985cited by this paper

• Virus-mediated immunosuppression in head and neck cancer

  2025cites this paper
• The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis

  2021cites this paper
• Glycogene expression profiles from a HaCaT cell line stably transfected with HPV16 E5 oncogene

  2020cites this paper
• Cellular Functions of HPV16 E5 Oncoprotein during Oncogenic Transformation

  2020cites this paper
• Impact of HPV E5 on viral life cycle via EGFR signaling.

  2019cites this paper
• YIP1 family member 4 (YIPF4) is a novel cellular binding partner of the papillomavirus E5 proteins

  2015cites this paper
• Human papillomavirus E5 oncoprotein: function and potential target for antiviral therapeutics

  2015cites this paper
• HPV Virology: Cellular Targets of HPV Oncogenes and Transformation

  2015cites this paper
• Sequence variants and functional analysis of human papillomavirus type 16 E5 gene in clinical specimens

  2014cites this paper
• The E5 proteins.

  2013cites this paper
• Molecular Bases of Human Papillomavirus Pathogenesis in the Development of Cervical Cancer

  2012cites this paper
• Prevaccination genomic diversity of human papillomavirus genotype 11: A study on 63 clinical isolates and 10 full‐length genome sequences

  2011cites this paper
• Papillomavirus E5: the smallest oncoprotein with many functions

  2011cites this paper
• IL-10 expression is regulated by HPV E2 protein in cervical cancer cells.

  2011cites this paper
• Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain.

  2010cites this paper
• Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.

  2010cites this paper
• The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1).

  2010cites this paper
• Unique properties of the canine papillomavirus type II E5 protein

  2009cites this paper
• The role of the ubiquitin proteasome pathway in papillomavirus pathogenicity

  2009cites this paper
• Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts

  2006cites this paper
• Diversifying Selection in Human Papillomavirus Type 16 Lineages Based on Complete Genome Analyses

  2005influential citation
• Terapia génica con citocinas contra cáncer cervicouterino

  2005cites this paper
• Terapia génica con citocinas contra cáncer cervicouterino

  2005cites this paper
• Cytotoxic-T-Lymphocyte Human Papillomavirus Type 16 E5 Peptide with CpG-Oligodeoxynucleotide Can Eliminate Tumor Growth in C57BL/6 Mice

  2004cites this paper
• The biochemical and biological functions of human papillomavirus type 16 E5 protein

  2003influential citation
• A Mitogenic Signal Triggered at an Early Stage of Vaccinia Virus Infection

  2001cites this paper
• The Expression of HPV-16 E5 Protein in Squamous Neoplastic Changes in the Uterine Cervix

  2001cites this paper
• Transcriptional repression of p21((Waf1/Cip1/Sdi1)) gene by c-jun through Sp1 site.

  2000cites this paper
• Human papillomavirus oncogenesis.

  2000cites this paper
• Simplifying the molecular mechanisms of human papillomavirus.

  1998cites this paper
• Human papillomavirus type 16 E5 protein (review).

  1997cites this paper